The Department of Dermatology at the University of Iowa is inviting volunteers for a clinical study using an investigational medicine for the treatment of Cutaneous T-cell Lymphoma (CTCL).

The purpose of this research study is to compare the effectiveness and safety of using a drug called LBH589 for the treatment of CTCL. L8H589 is considered investigational, which means that it has not been approved by the U.S. Food and Drug Administration for the treatment of CTCL.

Volunteers must be at least 18 years of age with a clinical diagnosis of CTCL in stage IB to IVA and must have tried at least two other systemic treatments such as oral bexarotene, PUVA, photophoresis, chemotherapy (such as methotrexate) or interferon.

If you are interested in participating or learning more about the study, please contact the Dermatology Clinical Trials Office at (319) 353-6439 for more information.